Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAS2R4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | RALGPS1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | ZNF607 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | THNSL2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | DISP1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | HFM1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | SP1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | AC090154.1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | NME9 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | PLEKHN1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |